Phillips, W., Johnsen, T., Caldwell, N. and Chaudhuri, J.
The difficulties of supplying new technologies into highly regulated markets: the case of tissue engineering.
Technology Analysis and Strategic Management, 23 (3).
Publisher's URL: http://dx.doi.org/10.1080/09537325.2011.550391
This study provides an insight into the difficulties companies encounter in transposing basic science into commercially viable healthcare technologies, focusing on the issue of establishing a dominant supply model within a highly regulated market. The core issue is how to scale-up customized scientific processes into products able to supply wider and possibly mass, markets. In tracing the development of approaches to scaling-up, the paper highlights the influence regulatory regimes have on high technology regulated products and services. The paper details the implications of two contrasting supply initiatives towards operationalizing tissue engineering, based on differences in regulatory regimes between Europe and the US.
|Additional Information:||This is an electronic version of an article published in "Phillips, Wendy and Johnsen, Thomas and Caldwell, Nigel and Chaudhuri, Julian (2011) The difficulties of supplying new technologies into highly regulated markets: the case of tissue engineering. Technology Analysis and Strategic Management, 23 (3). pp. 213-226". Technology Analysis and Strategic Management is available online at:
|Uncontrolled Keywords:||new technologies, supply, regulation|
|Faculty/Department:||Faculty of Business and Law > Department of Business Management|
Dr W. Phillips
|Deposited On:||17 Dec 2010 15:46|
|Last Modified:||13 Aug 2013 16:49|
Request a change to this item
Total Document Downloads in Past 12 Months